IP Library › Granted Patent US 7,649,085
Granted Patent B2
US 7,649,085 · App. 11/420,502 · Granted Jan 19, 2010

Saquinavir conjugates and antibodies useful in immunoassay

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,649,085
App. No.
11/420,502
Granted
Jan 19, 2010
Kind
B2
Abstract

Activated haptens useful for generating immunogens to HIV protease inhibitors, immunogens useful for producing antibodies to HIV protease inhibitors, and antibodies and labeled conjugates useful in immunoassays for the HIV protease inhibitor saquinavir. The novel haptens feature an activated functionality at the central, non-terminal hydroxyl group. Also described are monoclonal antibodies specific for saquinavir having less than 10% cross-reactivity with lopinavir, nelfinavir, amprenavir, ritonavir, and indinavir, and a murine hybridoma producing said antibodies.

Claims (9)

1. The compound O c -(succinimido-oxycarbonyl-butyryl-aminocaproyl)-saquinavir.

2. The compound of O c -[4′-(succinimido-oxycarbonyl)-benzoyl-aminocaproyl]-saquinavir.

3. The compound of O c -[4′-(succinimido-oxycarbonyl)-phenyl-aminocaproyl]-saquinavir.

4. The compound of O c -(succinimido-oxycarbonyl-methylaminocarbonyl)-saquinavir.

5. The compound of O c -[4′-(succinimido-oxycarbonyl)-phenyl-methylamino- co -glycyl-carbonyl]-saquinavir.

6. The compound O c -(succinimido-oxycarbonyl-butyryl-aminocaproyl)-saquinavir conjugate with KLH.

7. The compound O c -[4′-(succinimido-oxycarbonyl)-benzoyl-aminocaproyl]-saquinavir conjugate with BSA.

8. Murine hybridoma SAQ 10.2.1 having ATCC No. PTA-3973.

9. Murine hybridoma SAQ 14.1.1 having ATCC No. PTA-3974.